WILLIAM PEACOCK to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.390
-
Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure. J Manag Care Spec Pharm. 2017 Apr; 23(4-a Suppl):S10-S19.
Score: 0.123
-
Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program. Circ Cardiovasc Qual Outcomes. 2014 Mar; 7(2):227-35.
Score: 0.099
-
Impact of Society of Cardiovascular Patient Care accreditation on quality: an ACTION Registry?-Get With The Guidelines? analysis. Crit Pathw Cardiol. 2013 Sep; 12(3):116-20.
Score: 0.096
-
Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease. Am J Med. 2015 Apr; 128(4):426.e1-9.
Score: 0.026
-
Venous thromboembolism prophylaxis in hospitalized heart failure patients. J Card Fail. 2008 Mar; 14(2):127-32.
Score: 0.016
-
Optimizing treatment and outcomes in acute heart failure: beyond initial triage. Congest Heart Fail. 2006 May-Jun; 12(3):137-45.
Score: 0.014
-
Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol. 2006 Jun 15; 97(12):1707-12.
Score: 0.014